Company Revenue

The company grew in the low double-digits for 1Q23, driven by easier comps from the prior year, easing market pressure...

The company's spine business declined in the high-single-digits in 1Q23 but will benefit from more commercial focus in 2023....

SI-BONE reported 1Q23 orthopedic sales of $32.7 million, +45.8% compared to the first quarter of 2021. A stabilizing macro environment, robust...

The company grew in the low double-digits due to improving procedure volumes and continued sales force execution....

The company's orthopedics business grew in the low-single digits for 1Q23 due to improved procedure volumes and execution....

The company grew 22% in 1Q23 due to improving surgical volumes and working through its warehouse-driven backlog from late-2022....

Excluding the impact of currency translation, the company grew in the mid-single digits for the first quarter of 2023....

The company's orthopedic sales grew in the high single digits for 2022, and it launched new cornerstone products in high-growth...

With the exception of the pandemic-ridden 2020, OrthoPediatrics has grown in excess of 20% every year since its founding....

The company grew in the low single digits in 2022 as international growth in its orthopedics line offset competitive pressures...